Thrombosis in conversation podcast

Episode 30: VTE and AF at ESC 2025

0:00
36:15
Recuar 15 segundos
Avançar 15 segundos

“I think this was such an important trial, certainly one that has changed my practice already.” Dr Barnes welcomes Dr Marco Proietti for a review and discussion of key studies presented at ESC 2025, including AMALFI, ALONE-AF, and HI-PRO. Which results were practice-changing, which were reassuring, and which are of uncertain value or highlight a need for new therapeutics?

Mais episódios de "Thrombosis in conversation"